z-logo
open-access-imgOpen Access
Targeting of PI3K/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance
Author(s) -
Montserrat Estruch,
Camilla Vittori,
Teresa Muñoz Montesinos,
Kristian Reckzeh,
Kim TheilgaardMönch
Publication year - 2021
Publication title -
cancer drug resistance
Language(s) - English
Resource type - Journals
ISSN - 2578-532X
DOI - 10.20517/cdr.2021.76
Subject(s) - pi3k/akt/mtor pathway , myeloid leukemia , cancer research , chemotherapy , protein kinase b , dna repair , dna damage , medicine , leukemia , dna damage repair , myeloid , signal transduction , biology , immunology , dna , microbiology and biotechnology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom